Immune cell metabolic reprogramming in pancreatic cancer: roles in tumor progression and therapeutic strategies
Pancreatic cancer is one of the most lethal malignancies of the digestive system, and its profoundly immunosuppressive tumor microenvironment (TME) represents a major driver of tumor progression and therapeutic resistance. Emerging evidence indicates that metabolic reprogramming profoundly influences the polarization,...